1FW2.F WUXI BIOLOGICS-00000083

Healthcare Biotechnology Frankfurt Exchange
5.60 EUR
Close of Nov 11, 2026
3.21 6.55
Market cap
EUR 23.1B
P/E
37.3x
P/B
3.58x
ROE
10.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 1FW2.F undervalued?

Graham number
Price5.60
Graham value2.30
Premium143.7%

1FW2.F trades 143.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

WUXI BIOLOGICS-00000083 fundamental analysis

No fundamental analysis for WUXI BIOLOGICS-00000083 yet.

WUXI BIOLOGICS-00000083 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About WUXI BIOLOGICS-00000083

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstre…

Full company profile